Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04075747
Title A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia (V-FAST)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jazz Pharmaceuticals

acute myeloid leukemia


CPX-351 + Enasidenib

CPX-351 + Venetoclax

CPX-351 + Midostaurin

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.